Imunon Statistics

Total Valuation

Imunon has a market cap or net worth of $11.75 million. The enterprise value is $10.46 million.

Market Cap	11.75M
Enterprise Value	10.46M

Important Dates

The next confirmed earnings date is Monday, May 12, 2025, before market open.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Imunon has 14.50 million shares outstanding. The number of shares has increased by 37.24% in one year.

Current Share Class	14.50M
Shares Outstanding	14.50M
Shares Change (YoY)	+37.24%
Shares Change (QoQ)	+0.24%
Owned by Insiders (%)	1.54%
Owned by Institutions (%)	2.93%
Float	12.27M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	25.77
P/TBV Ratio	27.26
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.88, with a Debt / Equity ratio of 2.23.

Current Ratio	0.88
Quick Ratio	0.50
Debt / Equity	2.23
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -397.54% and return on invested capital (ROIC) is -199.10%.

Return on Equity (ROE)	-397.54%
Return on Assets (ROA)	-107.77%
Return on Invested Capital (ROIC)	-199.10%
Return on Capital Employed (ROCE)	-1,715.16%
Revenue Per Employee	n/a
Profits Per Employee	-$711,730
Employee Count	25
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -40.88% in the last 52 weeks. The beta is 1.75, so Imunon's price volatility has been higher than the market average.

Beta (5Y)	1.75
52-Week Price Change	-40.88%
50-Day Moving Average	0.90
200-Day Moving Average	0.96
Relative Strength Index (RSI)	41.11
Average Volume (20 Days)	64,765

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-18.27M
Pretax Income	-20.13M
Net Income	-17.79M
EBITDA	-18.04M
EBIT	-18.27M
Earnings Per Share (EPS)	-$1.39

Full Income Statement

Balance Sheet

The company has $2.87 million in cash and $1.01 million in debt, giving a net cash position of $1.86 million or $0.13 per share.

Cash & Cash Equivalents	2.87M
Total Debt	1.01M
Net Cash	1.86M
Net Cash Per Share	$0.13
Equity (Book Value)	452,000
Book Value Per Share	0.03
Working Capital	-705,000

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Imunon does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-37.24%
Shareholder Yield	-37.24%
Earnings Yield	-144.39%
FCF Yield	n/a

Analyst Forecast

The average price target for Imunon is $21.50, which is 2,554.32% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$21.50
Price Target Difference	2,554.32%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on March 1, 2022. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	Mar 1, 2022
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a